Friday, 16 October 2026European Markets

ERAMET, CRH PLC Ord, Another 1 Companies Have A High Dividend Yield And Return On Equity In The Basic Materials Sector.

Loading stream...

(vianews) - eramet (era.pa) is among this list of stock assets with the highest dividend rate and return on equity on the basic materials sector.

financial asset price forward dividend yield return on equity
eramet (era.pa) €74.95 4.98% 9.28%
crh plc ord (crg.ir) €50.34 2.3% 13.67%
imcd (imcd.as) €117.80 1.91% 17.66%

several euronext companies pay out dividends to its shareholders. the dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.

1. eramet (era.pa)

4.98% forward dividend yield and 9.28% return on equity

eramet s.a. operates as a mining and metallurgical company in france, asia, europe, north america, and internationally. the company extracts and processes manganese ore and nickel ore; and extracts and develops mineral sands. it also produces ferronickel, nickel pig iron, briquettes, nickel salts, high purity nickel, nickel ferroalloys, and alloy steel and casting; manganese alloys, such as high-carbon ferromanganese, silicomanganese, low and medium-carbon ferromanganese, and low-carbon silicomanganese for use in batteries, pigments, construction, and automotive industries; and mineral sands, such as titanium dioxide, high-purity pig iron, zircon, and ilmenite used in ceramics and pigments. in addition, it operates moanda mine in gabon; nickel mines in new caledonia and indonesia; and mineral sand mine in senegal and argentina. eramet s.a. was incorporated in 1880 and is headquartered in paris, france.

earnings per share

as for profitability, eramet has a trailing twelve months eps of €8.87.

pe ratio

eramet has a trailing twelve months price to earnings ratio of 8.45. meaning, the purchaser of the share is investing €8.45 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 9.28%.

dividend yield

as maintained by morningstar, inc., the next dividend payment is on may 26, 2023, the estimated forward annual dividend rate is 3.5 and the estimated forward annual dividend yield is 4.98%.

stock price classification

according to the stochastic oscillator, a useful indicator of overbought and oversold conditions, eramet's stock is considered to be overbought (>=80).

more news about eramet.

2. crh plc ord (crg.ir)

2.3% forward dividend yield and 13.67% return on equity

crh plc, through its subsidiaries, manufactures and distributes building materials in ireland and internationally. it operates through three segments: americas materials, europe materials, and building products. the company manufactures and supplies cement, lime, aggregates, precast, ready mixed concrete, and asphalt products; concrete masonry and hardscape products comprising pavers, kerbs, retaining walls, and related patio products; it also offers precast concrete and polymer-based products, such as underground vaults, drainage pipes and structures, utility enclosures, and modular precast structures to the water, energy, communication, transportation, and building structures markets; and construction accessories, such as engineered anchoring, fixing, and connection solutions, as well as lifting systems, formwork accessories, and other accessories used in construction applications. in addition, the company offers network access products, which include composite access chambers, covers, passive safety systems, retention sockets, sealants, and meter boxes; and paving and construction services. further, it provides building and civil engineering contracting, contract surfacing, operates logistics and owned railway infrastructure; sells and distributes cement; and supplies access chambers and ducting products. crh plc was founded in 1936 and is headquartered in dublin, ireland.

earnings per share

as for profitability, crh plc ord has a trailing twelve months eps of €3.6.

pe ratio

crh plc ord has a trailing twelve months price to earnings ratio of 13.98. meaning, the purchaser of the share is investing €13.98 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 13.67%.

volume

today's last reported volume for crh plc ord is 4366440 which is 61.43% above its average volume of 2704690.

revenue growth

year-on-year quarterly revenue growth grew by 7.6%, now sitting on 33.86b for the twelve trailing months.

more news about crh plc ord.

3. imcd (imcd.as)

1.91% forward dividend yield and 17.66% return on equity

imcd n.v. distributes, markets, and sells specialty chemicals and ingredients in the netherlands, rest of europe, the middle east, africa, north america, south america, and the asia-pacific. the company offers bioactives, biocides, chelates, functional additives, rheology modifiers, silicones, solubilisers, and solvents; active pharmaceutical, agrochemicals, biopharma, excipients and formulation, nutraceuticals, and regulated synthesis; actives, uv sunscreens, rheology modifiers, thickeners, surfactants, emulsifiers, emollients, elastomers, humectants, waxes, film formers, functional powders, hair styling polymers, hair conditioners, solvents, solubilizers, pigments, pearls, colorants, opacifiers, pearlisers, preservatives, antioxidants, additives, fragrances, and essential oils; and resins and binders, additives, functional fillers, and specialty solvents. it also provides taste, texture, nutrition, and function; base oil, fuel addictive, lubricants addictive, lubricants finished fluids, solvents, degreasers and fuel, compounds, and upstream, midstream and downstream oil, gas and energy; bio-based chemicals, binders, corrosion inhibitors, catalysts, intermediates, monomers, organic building blocks, processing aids, reactive diluents, solvents, and surfactants. imcd n.v. was founded in 1995 and is headquartered in rotterdam, the netherlands.

earnings per share

as for profitability, imcd has a trailing twelve months eps of €5.06.

pe ratio

imcd has a trailing twelve months price to earnings ratio of 23.28. meaning, the purchaser of the share is investing €23.28 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 17.66%.

growth estimates quarters

the company's growth estimates for the present quarter is 7% and a drop 32.3% for the next.

revenue growth

year-on-year quarterly revenue growth declined by 1.3%, now sitting on 4.59b for the twelve trailing months.

more news about imcd.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biopharma Catalyst Cluster: Late-Stage Readouts and Regulatory Milestones
October 2026 brings a dense run of Phase 3 wins (ALOFT-IPF, RESTORE-3), new data presentations (Roche, Bayer, Lilly, Vertex, Galderma) and regulatory steps (FDA acceptance of Roche's vamikibart BLA, Scholar Rock's EMA resubmission). The next big catalyst is the ivonescimab FDA PDUFA date on 2026-11-14. Obesity combination studies (REDEFINE 4, TOGETHER-PsO) and the 2027 Maritime-1 completion point to more catalysts ahead. QAIAx's speculative AI-linked trial claims (the QIII pilot, targeted for 2027) are an unrelated micro-cap sideshow with weak evidence, and have little in common with the large-cap pipeline news.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,378 source documents archived
Query this data → isubstrate.com